CR.NYSECrane CO

8-K: Crane Company Exceeds Expectations in Q1 2024, Raises Full-Year EPS Guidance

Sentiment:

Quarterly Report


Crane Company reported strong first-quarter results, including a 5% core sales growth and an 11% increase in core orders and backlog, leading to an increased full-year adjusted EPS guidance.

Better than expectedThe company raised its full-year adjusted EPS guidance, indicating better than expected performance.The company reported a 5% core sales growth and an 11% increase in core orders and backlog, exceeding previous expectations.

Summary

  • Crane Company announced its first-quarter 2024 results, showcasing a strong start to the year.
  • The company achieved a 5% year-over-year core sales growth and an 11% increase in both core orders and backlog.
  • First-quarter GAAP earnings per diluted share (EPS) were $1.12, compared to $0.98 in the same period last year.
  • Adjusted EPS for the quarter was $1.22, slightly down from $1.26 in the first quarter of 2023.
  • Total sales increased by 10%, with 5% from core sales, 5% from acquisitions, and a slight benefit from foreign exchange.
  • Operating profit from continuing operations rose by 15% to $89 million, while adjusted operating profit increased by 6% to $97 million.
  • The company's cash balance stood at $219 million, with total debt of $357 million as of March 31, 2024.
  • Crane has agreed to acquire CryoWorks, Inc. for approximately $61 million, a strategic move to bolster its Hydrogen business.
  • Full-year adjusted EPS guidance has been raised to a range of $4.75 to $5.05, up from the previous range of $4.55 to $4.85.
  • A second-quarter dividend of $0.205 per share was declared, payable on June 12, 2024.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to strong sales growth, increased backlog, raised EPS guidance, and a strategic acquisition. While there are some challenges, the overall tone is optimistic and confident.

Positives

  • Crane Company demonstrated strong sales growth, particularly in the Aerospace & Electronics segment.
  • The increase in orders and backlog suggests continued demand for the company's products and services.
  • The acquisition of CryoWorks is a strategic move that aligns with the company's growth initiatives in the hydrogen sector.
  • The company's balance sheet remains strong, providing financial flexibility for future investments.
  • The raised full-year adjusted EPS guidance indicates management's confidence in the company's performance for the remainder of the year.
  • The company is maintaining a consistent dividend payout to shareholders.

Negatives

  • Adjusted EPS for the first quarter of 2024 was slightly lower than the same period last year, at $1.22 compared to $1.26.
  • The Process Flow Technologies segment experienced a 2% decline in core sales.
  • The Engineered Materials segment saw a 12% decrease in sales compared to the prior year.
  • Cash used by operating activities was $80 million, resulting in a negative free cash flow of $89 million, though this is consistent with normal seasonality.
  • There are still some persistent supply chain challenges at Aerospace & Electronics, and ongoing weakness in the European Chemical markets.

Risks

  • The company faces risks related to global economic conditions, including inflationary pressures and geopolitical instability.
  • There are potential risks associated with information systems and technology network failures and breaches in data security.
  • The company's ability to source components and raw materials from suppliers could be disrupted.
  • Demand for the company's products is variable and subject to factors beyond its control.
  • The company faces risks from environmental liabilities, costs, litigation and violations.
  • There are risks associated with conducting a substantial portion of the business outside the U.S.
  • The company may be unable to identify or complete acquisitions, or to successfully integrate the businesses it acquires.
  • There is a risk of adverse impacts from intangible asset impairment charges.
  • The company faces potential product liability or warranty claims.
  • The company may be unable to successfully develop and introduce new products.
  • There is significant competition in the company's markets.
  • The company faces additional tax expenses or exposures that could affect its financial condition.
  • There is a risk of inadequate or ineffective internal controls.

Future Outlook

Crane Company has raised its full-year adjusted EPS guidance to a range of $4.75 to $5.05, reflecting confidence in its performance for the remainder of the year. The revised guidance assumes the CryoWorks acquisition is completed on April 30, 2024. Total sales growth is expected to be approximately 10%, driven by core sales growth of approximately 4% to 6% and an acquisition benefit of approximately 5%. Adjusted segment operating margin is expected to be around 20.5%.

Management Comments

  • Max Mitchell, Crane's Chairman, President and Chief Executive Officer, stated: 'Crane is off to a great start in 2024, with strong results reflecting continued differentiated execution and accelerating results from growth initiatives.'
  • Mr. Mitchell added: 'We are also pleased to announce that we signed an agreement to acquire CryoWorks, a leading supplier of vacuum insulated pipe systems for hydrogen and cryogenic applications which is highly synergistic with the ongoing organic development of our CRYOFLO brand.'
  • Mr. Mitchell concluded: 'With the first quarter of 2024 behind us, we are extremely confident about our opportunities and prospects in the quarters and years ahead.'
  • Rich Maue, Crane's Executive Vice President and Chief Financial Officer, added: 'Our balance sheet remains very strong, and our low leverage, along with our consistently strong cash flow generation, continues to provide us with significant financial flexibility for further capital deployment.'

Industry Context

Crane's performance reflects a positive trend in the aerospace and process flow technology sectors, with strong demand and growth in key areas. The acquisition of CryoWorks highlights the company's strategic focus on the growing hydrogen market. The company's results are being achieved despite some supply chain challenges and weakness in the European chemical markets, indicating a strong underlying business performance.

Comparison to Industry Standards

  • Crane's 5% core sales growth is solid, but it is important to compare this to peers such as Parker Hannifin (PH) and Eaton Corporation (ETN), which also operate in similar industrial sectors. Parker Hannifin recently reported a 6% organic sales growth in their latest quarter, while Eaton reported a 10% organic growth, suggesting Crane is performing well but not leading the pack.
  • The 11% backlog growth is a positive sign, indicating future revenue potential. Companies like Honeywell (HON) and General Electric (GE) also have significant backlogs in their aerospace divisions, but specific comparisons would require a deeper dive into their respective reports.
  • Crane's adjusted EPS of $1.22 is a key metric. Comparing this to companies like Roper Technologies (ROP) and Fortive (FTV) in the industrial technology space, which often have higher margins, would provide a better understanding of Crane's profitability relative to its peers.
  • The acquisition of CryoWorks for $61 million is a strategic move into the hydrogen market. This is similar to moves by companies like Chart Industries (GTLS) and Plug Power (PLUG), which are also investing heavily in hydrogen technologies. The success of this acquisition will depend on Crane's ability to integrate CryoWorks and capitalize on the growing hydrogen market.
  • Crane's adjusted operating margin of 17.1% is a good indicator of profitability. Comparing this to the margins of companies like Emerson Electric (EMR) and Rockwell Automation (ROK) would provide a better understanding of Crane's operational efficiency. These companies often have higher margins due to their focus on automation and software solutions.

Stakeholder Impact

  • Shareholders will benefit from the increased EPS guidance and continued dividend payments.
  • Employees may see increased job security and opportunities due to the company's growth.
  • Customers will benefit from the company's continued innovation and technology-led solutions.
  • Suppliers may see increased business opportunities due to the company's growth.
  • Creditors will be reassured by the company's strong balance sheet and cash flow generation.

Next Steps

  • Crane will complete the acquisition of CryoWorks on April 30, 2024.
  • The company will continue to execute its growth initiatives and focus on its strategic growth platforms.
  • Crane will hold a conference call on April 23, 2024, to discuss the first quarter financial results.
  • The company will pay a second-quarter dividend of $0.205 per share on June 12, 2024.

Key Dates

DateDescription
April 3, 2023Completion of the separation transaction from Crane Holdings, Co.
March 31, 2024End of the first quarter of 2024, financial results reported.
April 22, 2024Date of the earnings press release and 8-K filing.
April 23, 2024Scheduled conference call to discuss first quarter financial results.
April 30, 2024Expected closing date of the CryoWorks acquisition.
May 31, 2024Shareholders of record date for the second quarter dividend.
June 12, 2024Payment date for the second quarter dividend.

Keywords

Crane Company, Financial Results, Earnings, EPS, Acquisition, CryoWorks, Hydrogen, Aerospace, Process Flow Technologies, Backlog, Dividend, Guidance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.